Skip to main content

Public tenders

Tenders in Pharmaceutical products

Live results from every procurement portal we monitor. Refine the search using the filter bar above.

108 matching · page 5 of 5

Albaniasupplies

Lot 3 Piperacillin + Tazobactam 4 gr + 500 mg

Drejtoria e Spitalit Rajonal Shkoder

Estimated value
REF-85479-05-13-2026
Albaniasupplies

Blerje Ilace dhe materiale mjeksore

Qendra Shendetesore Koder Kamez Tirane

Estimated value
REF-85404-05-13-2026
Albaniasupplies

Lot 2 Imipenem + Cilastatin 500 mg + 500 mg

Drejtoria e Spitalit Rajonal Shkoder

Estimated value
REF-85475-05-13-2026
Albaniasupplies

Lot 1 Meropenem 1gr

Drejtoria e Spitalit Rajonal Shkoder

Estimated value
REF-85473-05-13-2026
Albaniasupplies

Lot 4 Oxytocin 10 UI/ml

Drejtoria e Spitalit Rajonal Shkoder

Estimated value
REF-85482-05-13-2026
United Kingdomservices
closing in 3 days

Compounded mAbs - Cancer Therapies

Berkshire Healthcare NHS Foundation Trust

Phamacy Procurement Contract - A ranked framework for the supply and delivery of Compounded Monoclonal Antibodies (mAbs) for Intravenous Infusion for Chemotherapy indications split into 2 lots: Lot 1: High Volume Products - 5 molecules / all brands Lot 2: Lower Volume Products - 13 molecules / all brands The ranked framework will be open to the participating Trusts of the South East Pharmacy Procurement Service (SEPPS): Thames Valley and Wessex (TV&W) 1. Buckinghamshire Healthcare NHS Trust 2. Frimley Health NHS Foundation Trust 3. Hampshire Hospitals NHS Foundation Trust 4. Isle of Wight NHS Trust 5. Hampshire and Isle of Wight Healthcare NHS Foundation Trust 6. Milton Keynes University Hospital NHS Foundation Trust 7. Oxford Health NHS Foundation Trust 8. Oxford University Hospitals NHS Foundation Trust 9. Portsmouth Hospitals NHS Trust 10. Royal Berkshire NHS Foundation Trust 11. University Hospital Southampton NHS Foundation Trust South-East Coast (SEC) 12. Ashford and St. Peters’ Hospitals NHS Foundation Trust 13. Dartford and Gravesham NHS Trust 14. East Kent Hospitals University NHS Foundation Trust 15. East Sussex Healthcare NHS Trust 16. Kent Community Health NHS Trust 17. Maidstone & Tunbridge Wells NHS Trust 18. Medway NHS Foundation Trust 19. Queen Victoria Hospitals NHS Foundation Trust 20. Royal Surrey County Hospital NHS Foundation Trust 21. Surrey and Borders Partnership NHS Foundation Trust 22. Surrey and Sussex Healthcare NHS Trust 23. Sussex Community NHS Trust 24. Sussex Partnership NHS Foundation Trust 25. University Hospitals Sussex NHS Foundation Trust 26. Berkshire Healthcare NHS Foundation Trust This framework will be available for use by Trusts in East of England and London regions, but the volumes for these regions have not been included for adjudication as part of the tender process. SEC Trusts can utilise this tender for products or services not covered by the National unlicensed aseptically prepared cytotoxic medicines and mAbs framewor

Estimated value£216.0m
PR BHFT 0715
United Kingdomservices
closing in 3 days

Compounded mAbs - Cancer Therapies

Berkshire Healthcare NHS Foundation Trust

Phamacy Procurement Contract - A ranked framework for the supply and delivery of Compounded Monoclonal Antibodies (mAbs) for Intravenous Infusion for Chemotherapy indications split into 2 lots: Lot 1: High Volume Products - 5 molecules / all brands Lot 2: Lower Volume Products - 13 molecules / all brands The ranked framework will be open to the participating Trusts of the South East Pharmacy Procurement Service (SEPPS): Thames Valley and Wessex (TV&W) 1. Buckinghamshire Healthcare NHS Trust 2. Frimley Health NHS Foundation Trust 3. Hampshire Hospitals NHS Foundation Trust 4. Isle of Wight NHS Trust 5. Hampshire and Isle of Wight Healthcare NHS Foundation Trust 6. Milton Keynes University Hospital NHS Foundation Trust 7. Oxford Health NHS Foundation Trust 8. Oxford University Hospitals NHS Foundation Trust 9. Portsmouth Hospitals NHS Trust 10. Royal Berkshire NHS Foundation Trust 11. University Hospital Southampton NHS Foundation Trust South-East Coast (SEC) 12. Ashford and St. Peters’ Hospitals NHS Foundation Trust 13. Dartford and Gravesham NHS Trust 14. East Kent Hospitals University NHS Foundation Trust 15. East Sussex Healthcare NHS Trust 16. Kent Community Health NHS Trust 17. Maidstone & Tunbridge Wells NHS Trust 18. Medway NHS Foundation Trust 19. Queen Victoria Hospitals NHS Foundation Trust 20. Royal Surrey County Hospital NHS Foundation Trust 21. Surrey and Borders Partnership NHS Foundation Trust 22. Surrey and Sussex Healthcare NHS Trust 23. Sussex Community NHS Trust 24. Sussex Partnership NHS Foundation Trust 25. University Hospitals Sussex NHS Foundation Trust 26. Berkshire Healthcare NHS Foundation Trust This framework will be available for use by Trusts in East of England and London regions, but the volumes for these regions have not been included for adjudication as part of the tender process. SEC Trusts can utilise this tender for products or services not covered by the National unlicensed aseptically prepared cytotoxic medicines and mAbs framewor

Estimated value£216.0m
042148-2026
United Kingdomsupplies

PR BHFT 0796 - Supply of Dose Banded Compounded Chemotherapy

Berkshire Healthcare NHS Foundation Trust

Pharmacy Procurement Contract - A ranked framework for the supply and delivery of Supply of Dose banded compounded chemotherapy split into 2 lots: Lot 1: High Volume Products - 7 molecules / all brands Lot 2: Low Volume Products - 22 molecules / all brands The ranked framework will be open to the participating Trusts of the South East Pharmacy Procurement Service (SEPPS) as follows: 1. Ashford and St Peters Hospital NHS Foundation Trust 2. Berkshire Healthcare NHS Foundation Trust 3. Buckinghamshire Healthcare NHS Trust 4. Dartford and Gravesham NHS Trust 5. East Kent Hospitals NHS Foundation Trust 6. East Sussex Healthcare NHS Trust 7. Frimley Health NHS Foundation Trust 8. Hampshire and Isle of Wight Healthcare NHS Foundation Trust 9. Hampshire Hospitals NHS Foundation Trust 10. Isle of Wight NHS Trust 11. Kent Community Health NHS Trust 12. Maidstone and Tunbridge Wells NHS Trust 13. Medway NHS Foundation Trust 14. Milton Keynes University Hospital NHS Foundation Trust 15. Oxford Health NHS Foundation Trust 16. Oxford University Hospitals NHS Foundation Trust * 17. Portsmouth Hospitals NHS Trust 18. Queen Victoria Hospitals NHS Foundation Trust 19. Royal Berkshire NHS Foundation Trust 20. Royal Surrey County Hospital NHS Foundation Trust 21. Surrey and Borders Partnership NHS Foundation Trust 22. Surrey and Sussex Healthcare NHS Trust 23. Sussex Community NHS Trust 24. Sussex Partnership NHS Foundation Trust 25. University Hospital Southampton NHS Foundation Trust 26. University Hospitals Sussex NHS Foundation Trust This framework will also be available for use by Trusts in East of England and London regions, but the volumes for these regions have not been included for adjudication as part of the tender process. SEC Trusts can utilise this tender for products or services not covered by the National unlicensed aseptically prepared cytotoxic medicines and Dose banded compounded chemotherapy framework via MPSC. Please note: we did not publish a preliminary market en

Estimated value£8.6m
PR BHFT 0796
United Kingdomsupplies

PR BHFT 0796 - Supply of Dose Banded Compounded Chemotherapy

Berkshire Healthcare NHS Foundation Trust

Pharmacy Procurement Contract - A ranked framework for the supply and delivery of Supply of Dose banded compounded chemotherapy split into 2 lots: Lot 1: High Volume Products - 7 molecules / all brands Lot 2: Low Volume Products - 22 molecules / all brands The ranked framework will be open to the participating Trusts of the South East Pharmacy Procurement Service (SEPPS) as follows: 1. Ashford and St Peters Hospital NHS Foundation Trust 2. Berkshire Healthcare NHS Foundation Trust 3. Buckinghamshire Healthcare NHS Trust 4. Dartford and Gravesham NHS Trust 5. East Kent Hospitals NHS Foundation Trust 6. East Sussex Healthcare NHS Trust 7. Frimley Health NHS Foundation Trust 8. Hampshire and Isle of Wight Healthcare NHS Foundation Trust 9. Hampshire Hospitals NHS Foundation Trust 10. Isle of Wight NHS Trust 11. Kent Community Health NHS Trust 12. Maidstone and Tunbridge Wells NHS Trust 13. Medway NHS Foundation Trust 14. Milton Keynes University Hospital NHS Foundation Trust 15. Oxford Health NHS Foundation Trust 16. Oxford University Hospitals NHS Foundation Trust * 17. Portsmouth Hospitals NHS Trust 18. Queen Victoria Hospitals NHS Foundation Trust 19. Royal Berkshire NHS Foundation Trust 20. Royal Surrey County Hospital NHS Foundation Trust 21. Surrey and Borders Partnership NHS Foundation Trust 22. Surrey and Sussex Healthcare NHS Trust 23. Sussex Community NHS Trust 24. Sussex Partnership NHS Foundation Trust 25. University Hospital Southampton NHS Foundation Trust 26. University Hospitals Sussex NHS Foundation Trust This framework will also be available for use by Trusts in East of England and London regions, but the volumes for these regions have not been included for adjudication as part of the tender process. SEC Trusts can utilise this tender for products or services not covered by the National unlicensed aseptically prepared cytotoxic medicines and Dose banded compounded chemotherapy framework via MPSC. Please note: we did not publish a preliminary market en

Estimated value£8.6m
036321-2026
United Kingdomsupplies
closing in 3 days

NHS National Generic Pharmaceuticals - Wave 16a

NHS England

NHS National Framework for Generics Pharmaceuticals Wave 16a Offer reference number: CM/PHG/24/5714 Period of framework agreement: Dates detailed below, with an option or options to extend (at the authority’s discretion) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement: CM/PHG/24/5714/01 Oral (plus non-parenteral) products: CESW/LSNE/NWLN: 01/02/2027 to 31/05/2030 (40 months) CM/PHG/24/5714/02 Hospital only products: DLN: 01/02/2027 to 31/01/2029 (24 months) DNW: 01/02/2027 to 31/01/2029 (24 months) CM/PHG/24/5714/03 Hospital only (housekeeping) products: DCE/DSW: 01/02/2027 to 30/09/2027 (8 months) DLS/DNE: 01/02/2027 to 31/05/2028 (16 months)

Estimated value£799.3m
CM/PHG/24/5714
United Kingdomsupplies
closing in 3 days

NHS National Generic Pharmaceuticals - Wave 16a

NHS England

NHS National Framework for Generics Pharmaceuticals Wave 16a Offer reference number: CM/PHG/24/5714 Period of framework agreement: Dates detailed below, with an option or options to extend (at the authority’s discretion) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement: CM/PHG/24/5714/01 Oral (plus non-parenteral) products: CESW/LSNE/NWLN: 01/02/2027 to 31/05/2030 (40 months) CM/PHG/24/5714/02 Hospital only products: DLN: 01/02/2027 to 31/01/2029 (24 months) DNW: 01/02/2027 to 31/01/2029 (24 months) CM/PHG/24/5714/03 Hospital only (housekeeping) products: DCE/DSW: 01/02/2027 to 30/09/2027 (8 months) DLS/DNE: 01/02/2027 to 31/05/2028 (16 months)

Estimated value£799.3m
037725-2026
ItalySupplies

Italy – Pharmaceutical products – PROCEDURA APERTA, AI SENSI DEGLI ARTT. 59 C.. 4 E 71 D. LGS. 36/2023, FINALIZZATA ALLA CONCLUSIONE DI UN ACCORDO QUADRO MULTIFORNITORE PER L'AFFIDAMENTO DELLA FORNITURA TRAMITE DISTRIBUTORE INTERMEDIO DI FARMACI DI FASCIA A E C, PARAFARMACI E PRODOTTI DIETETICI

Azienda Sanitaria Provinciale Vibo Valentia - Settore Provveditorato Economato e Gestione Logistica

PROCEDURA APERTA, AI SENSI DEGLI ARTT. 59 C.. 4 E 71 D. LGS. 36/2023, FINALIZZATA ALLA CONCLUSIONE DI UN ACCORDO QUADRO MULTIFORNITORE PER L'AFFIDAMENTO DELLA FORNITURA TRAMITE DISTRIBUTORE INTERMEDIO DI FARMACI DI FASCIA A E C, PARAFARMACI E PRODOTTI DIETETICI

Estimated value€900,000
304771-2026

Free tender alerts

Get a weekly digest of new tenders

New new tenders matching your interests, delivered to your inbox — no app required. Tell us your email and we'll start a weekly digest. Add keywords or a minimum value in the message and we'll filter to match.

Opens your mail app pre-addressed. We only use your email for the digest you requested.